The role:

The Director of SEC Reporting and Technical Accounting is an experienced accounting and finance leader that will help build and run SEC reporting processes of our newly public and fast-moving clinical-stage biotechnology company. Reporting to the VP of Finance, this individual will own SEC reporting operations and related internal controls, including the preparation of financial statements and drafting and filing of 10-Qs/10-Ks and annual proxy. This individual will also own technical accounting, including reviewing new contracts for accounting implications and owning the analysis and drafting of technical accounting memos. This is a hands-on role that will collaborate with various internal and external partners, including non-finance operating teams.

Key responsibilities:

• Own the preparation and drafting of 10-Qs/10-Ks and annual proxy in accordance with US GAAP and SEC requirements on a timeline that meets internal and SEC reporting deadlines, including ensuring complete and accurate business updates, MD&A, financial statements and footnote disclosures.
• Develop and maintain SEC reporting policies, procedures, and internal controls that can scale in a newly public high growth environment.
• Manage external audit relationships and lead audit readiness processes.
• Own the accounting for equity compensation (ASC 718), income tax (ASC 740), and other technical accounts as assigned.
• Review new contracts, evaluate for proper accounting treatment, and team with FP&A to ensure proper budget and forecast treatment.
• Prepare or, if appropriate, supervise an external specialist in the preparation of technical accounting memos ensuring completeness and accuracy of conclusions in accordance with US GAAP.
• Administer the Company’s equity plan(s) including employee onboarding, grants, modifications, and terminations, coordinating with legal and HR as appropriate.
• Manage the Company’s annual income tax requirements including extensions, returns, and provision, coordinating with external tax providers as appropriate.
• Assist in the preparation of quarterly Disclosure Committee and Audit Committee communications.
• Implement and optimize an equity administration system (E*TRADE/EEO).
• Assist in the hiring and development of a small, high-performing accounting and finance team as the company scales

Required experience & skills:

• 10+ years of progressive finance and accounting experience, CPA required; public accounting background preferred
• Strong knowledge of public company requirements, including SEC reporting, internal controls (SOX), financial planning, and cross-functional alignment
• Deep technical accounting knowledge (US GAAP), including equity compensation (ASC 718), income tax (ASC 740), R&D accruals, clinical trial accounting, and pre-clinical/clinical stage company financials
• Experience managing Big 4 or national firm audits
• Prior experience supporting or executing a public offering (IPO, follow-on, crossover) preferred
• Demonstrated experience building finance and accounting infrastructure from the ground up in preparation for and through a biotechnology IPO preferred
• Excellent judgment, high integrity, and the ability to operate with minimal overhead in a fast-moving environment
• The right candidate thrives in a nimble environment, brings public company rigor to a private-stage company, and can build scalable systems without adding unnecessary overhead.
• Strong written and verbal communication skills with a collaborative, team-oriented approach
• Ability to thrive in a fast-paced, dynamic environment and remain comfortable with change and ambiguity
• Flexible, proactive, and hands-on mindset with a roll-up-your-sleeves, can-do attitude

Base Salary Range: $200,000 - $240,000

This role is also eligible for a competitive total rewards package, which may include an annual bonus, equity, and a comprehensive benefits offering.